155 related articles for article (PubMed ID: 34768464)
21. Serum NGAL, cystatin C and urinary NAG measurements for early diagnosis of contrast-induced nephropathy in children.
Benzer M; Alpay H; Baykan Ö; Erdem A; Demir IH
Ren Fail; 2016; 38(1):27-34. PubMed ID: 26584598
[TBL] [Abstract][Full Text] [Related]
22. Prevention of contrast-induced nephropathy with single bolus erythropoietin in patients with diabetic kidney disease: A randomized controlled trial.
Shema-Didi L; Kristal B; Eizenberg S; Marzuq N; Sussan M; Feldman-Idov Y; Ofir P; Atar S
Nephrology (Carlton); 2016 Apr; 21(4):295-300. PubMed ID: 26370061
[TBL] [Abstract][Full Text] [Related]
23. Biomarkers for early detection of sickle nephropathy.
Sundaram N; Bennett M; Wilhelm J; Kim MO; Atweh G; Devarajan P; Malik P
Am J Hematol; 2011 Jul; 86(7):559-66. PubMed ID: 21630304
[TBL] [Abstract][Full Text] [Related]
24. Serum neutrophil gelatinase-associated lipocalin and cystatin C are early biomarkers of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease.
Alharazy SM; Kong N; Saidin R; Gafor AH; Maskon O; Mohd M; Zakaria SZ
Angiology; 2014 May; 65(5):436-42. PubMed ID: 23580616
[TBL] [Abstract][Full Text] [Related]
25. Urinary transferrin pre-emptively identifies the risk of renal damage posed by subclinical tubular alterations.
Casanova AG; Vicente-Vicente L; Hernández-Sánchez MT; Prieto M; Rihuete MI; Ramis LM; Del Barco E; Cruz JJ; Ortiz A; Cruz-González I; Martínez-Salgado C; Pescador M; López-Hernández FJ; Morales AI
Biomed Pharmacother; 2020 Jan; 121():109684. PubMed ID: 31810121
[TBL] [Abstract][Full Text] [Related]
26. Laboratory Predictors of Contrast-Induced Nephropathy After Neurointervention: A Prospective 3-Year Observational Study.
Kim H; Jo K
World Neurosurg; 2020 Mar; 135():e77-e82. PubMed ID: 31698123
[TBL] [Abstract][Full Text] [Related]
27. Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy.
George B; Joy MS; Aleksunes LM
Exp Biol Med (Maywood); 2018 Feb; 243(3):272-282. PubMed ID: 29231123
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
[TBL] [Abstract][Full Text] [Related]
29. NGAL is an early predictive biomarker of contrast-induced nephropathy in children.
Hirsch R; Dent C; Pfriem H; Allen J; Beekman RH; Ma Q; Dastrala S; Bennett M; Mitsnefes M; Devarajan P
Pediatr Nephrol; 2007 Dec; 22(12):2089-95. PubMed ID: 17874137
[TBL] [Abstract][Full Text] [Related]
30. Prediction of contrast-induced nephropathy by the serum creatinine level on the day following cardiac catheterization.
Watanabe M; Saito Y; Aonuma K; Hirayama A; Tamaki N; Tsutsui H; Murohara T; Ogawa H; Akasaka T; Yoshimura M; Sato A; Takayama T; Sakakibara M; Suzuki S; Ishigami K; Onoue K;
J Cardiol; 2016 Nov; 68(5):412-418. PubMed ID: 26708123
[TBL] [Abstract][Full Text] [Related]
31. Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values?
Bachorzewska-Gajewska H; Malyszko J; Sitniewska E; Malyszko JS; Pawlak K; Mysliwiec M; Lawnicki S; Szmitkowski M; Dobrzycki S
Kidney Blood Press Res; 2007; 30(6):408-15. PubMed ID: 17901710
[TBL] [Abstract][Full Text] [Related]
32. Association of Kidney Function and Early Kidney Injury With Incident Hypertension in HIV-Infected Women.
Ascher SB; Scherzer R; Peralta CA; Tien PC; Grunfeld C; Estrella MM; Abraham A; Gustafson DR; Nowicki M; Sharma A; Cohen MH; Butch AW; Young MA; Bennett MR; Shlipak MG
Hypertension; 2017 Feb; 69(2):304-313. PubMed ID: 27993956
[TBL] [Abstract][Full Text] [Related]
33. Serum levels of neutrophil Gelatinase associated Lipocalin (NGAL) predicts hemodialysis after coronary angiography in high risk patients with acute coronary syndrome.
Reyes LF; Severiche-Bueno DF; Bustamante CA; Murillo S; Soni NJ; Poveda M; Gomez E; Buitrago R; Rodriguez A
BMC Nephrol; 2020 Apr; 21(1):143. PubMed ID: 32321453
[TBL] [Abstract][Full Text] [Related]
34. Valuable markers for contrast-induced nephropathy in patients undergoing cardiac catheterization.
Kato K; Sato N; Yamamoto T; Iwasaki YK; Tanaka K; Mizuno K
Circ J; 2008 Sep; 72(9):1499-505. PubMed ID: 18724030
[TBL] [Abstract][Full Text] [Related]
35. Ascorbic acid ameliorates renal injury in a murine model of contrast-induced nephropathy.
Rollins K; Noorani A; Janeckova L; Jones T; Griffiths M; Baker MP; Boyle JR
BMC Nephrol; 2017 Mar; 18(1):101. PubMed ID: 28340561
[TBL] [Abstract][Full Text] [Related]
36. Urinary interleukin-18 as an early indicator to predict contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.
He H; Li W; Qian W; Zhao X; Wang L; Yu Y; Liu J; Cheng J
Exp Ther Med; 2014 Oct; 8(4):1263-1266. PubMed ID: 25187836
[TBL] [Abstract][Full Text] [Related]
37. The Ratio of Fibrinogen to Albumin as a Predictor of Contrast-Induced Nephropathy After Carotid Angiography.
Ertas F; Avci E; Kiris T
Angiology; 2019 May; 70(5):458-464. PubMed ID: 30373374
[TBL] [Abstract][Full Text] [Related]
38. Albuminuria, proteinuria, and novel urine biomarkers as predictors of long-term allograft outcomes in kidney transplant recipients.
Nauta FL; Bakker SJ; van Oeveren W; Navis G; van der Heide JJ; van Goor H; de Jong PE; Gansevoort RT
Am J Kidney Dis; 2011 May; 57(5):733-43. PubMed ID: 21458900
[TBL] [Abstract][Full Text] [Related]
39. Coronary artery calcification scores improve contrast-induced nephropathy risk assessment in chronic kidney disease patients.
Osugi N; Suzuki S; Shibata Y; Tatami Y; Harata S; Ota T; Hayashi M; Yasuda Y; Ishii H; Shimizu A; Murohara T
Clin Exp Nephrol; 2017 Jun; 21(3):391-397. PubMed ID: 27339445
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit.
Doi K; Negishi K; Ishizu T; Katagiri D; Fujita T; Matsubara T; Yahagi N; Sugaya T; Noiri E
Crit Care Med; 2011 Nov; 39(11):2464-9. PubMed ID: 21705884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
